Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma

• Главные авторы: Zhou L (Автор), Lin J (Автор), Wu G (Автор), Chen J (Автор), Huang X (Автор), Zhang S (Автор)
• Формат: ‌
• Опубликовано: Dove Medical Press, 2020-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Liya Zhou,* Jie Lin,* Gang Wu, Jiawei Chen, Xiaopeng Huang, Shuai Zhang Department of Radiation Oncology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province 570311, People’s Republic of China*These authors contributed equally to this w...